Background: Solid cerebellar hemangioblastomas are highly vascular lesions and may cause catastrophic hemorrhage during excision. Methods: This retrospective study enrolled 10 patients (7 men and 3 women, with a mean age of 38.2 AE 12.5 years) with solid cerebellar hemangioblastomas. All patients had a solitary tumor and underwent surgical resection of the lesion through a suboccipital approach. The basic features, serial radiographic examinations, and operative records were analyzed. Results: The most common presenting symptoms were headache (100%), ataxia (100%), and long tract manifestations (60%). Three patients had experienced failed surgery previously due to massive intraoperative bleeding. Three patients were confirmed as having Von Hippel-Lindau disease. The average size of the tumor was 40.7 AE 8.7 mm in its maximal diameter (range 25-58 mm). Total endovascular occlusion obtained in six patients, near total occlusion in three patients, and incomplete occlusion in one patient. Nine (90.0%) patients underwent gross total resection and one (10.0%) underwent partial resection. After the primary surgery, eight (80.0%) patients experienced improvement in their symptoms, two (20.0%) maintained their pre-treatment status, and none showed neurological deterioration following tumor resection. Blood loss during surgery after embolization was minimal and controllable. Conclusion: Preoperative embolization improves safety and efficacy of the microsurgical excision of such tightly located very vascular tumors. Embolization changes the concept of this lesion surgery into piecemeal removal rather than a total mass extraction technique. Liquid agents are superior to particles in obliteration of such lesions.
Introduction
Cerebellar hemangioblastomas are known to be the most common primary tumor of the posterior fossa occurring among adults; they present as cystic in 70% of cases or as solid masses in about 30%. They occur either as a familial autosomal dominantly inherited Von Hippel-Lindau (VHL) disease in about 5-30% of cases, but also may manifest as a sporadic tumor. Hemangioblastomas are histologically benign lesions that comprise 1-2% of primary nervous system tumors and 8-12% of all posterior fossa lesions in adults. [1] [2] [3] These lesions are surgically challenging cases due to their high vascularity and their vicinity to neural and vascular structures in the tight posterior fossa, thus making total and safe surgical removal difficult. Dealing with these lesions basically requires different thinking. The surgeon has to circulate around the lesion to devascularize it 360 before its removal. Such a technique may not be easy within the tight posterior fossa. Preoperative embolization may improve surgery so that it is less bloody, easier, and complete. We hereby report our experience with 10 consecutive cases of large and giant solid cerebellar hemangioblastomas treated surgically after performing a super-selective angiographic embolization.
Patients and methods
We report our experience in dealing with 10 consecutive cases of large and giant solid cerebellar hemangioblastoma treated surgically after preoperative embolization between 2000 and 2014. A full medical history was available for all patients, who were subjected to a complete clinical examination. The patients were preoperatively evaluated by neuroimaging methods such as magnetic resonance imaging (MRI), contrast MRI, computed tomography angiography (CTA), and digital subtraction angiography (DSA). All cases signed an informed consent according to the local ethics committee in our university and all patients were followed postoperatively for at least 14 months. Clinical results were evaluated using the modified Rankin scale (MRS). Table 1 illustrates detailed clinical information about our patient group.
Technique of tumor embolization
Percutaneous femoral arterial catheterization was performed in all patients. General anesthesia and endotracheal intubation was used in all. A pre-embolization angiogram was done to determine the extent of tumor blush, feeding arteries, draining veins, and extracranialto-intracranial anastomoses. Embolizations were completed with polyvinyl alcohol (PVA) particles or liquid agents (Onyx, EV3 Inc., USA) and n-butyl cyanoacrylate (NBCA, Trufill, Cordis, Miami Lakes, FL). Superselective catheterization of the main feeding arteries was carried out using a suitable microcatheter.
Technique of PVA particle embolization
Contour Õ PVA particles (Boston Scientific, Fremont, CA) with a diameter of 150-450 mm were selected. The Contour Õ particles were mixed with saline and contrast medium before injection. When a reduction in arterial blood flow was observed, a control angiogram was obtained to assess residual flow toward the tumor. Super-selective catheterization of a remaining feeding artery was performed if necessary.
Technique of Onyx embolization
After super-selective navigation of the feeding artery, the dead space within the microcatheter was slowly filled with dimethyl sulfoxide followed by Onyx embolization using a subtracted roadmap. Embolization was continued until the desired degree of tumor penetrance or the maximal degree of Onyx reflux along the microcatheter was reached.
Technique of NBCA embolization
When a wedged position of the microcatheter inside the tumor was reached, a low concentration of NBCA (15-25%) was chosen for most cases to allow penetration inside the tumor. We first flushed the microcatheter with a 25% dextrose solution and then injected the NBCA mixture under roadmap fluoroscopy. To avoid trapping the microcatheter, the injection was stopped and the microcatheter was pulled if there was any minimal reflux.
Post-embolization care
Control angiography after embolization was done to assess the effectiveness of penetration of the embolic material into the tumor and decrease tumor vascularity. Patients were assessed clinically and radiologically after recovery using CT scan to exclude presence of hemorrhage, edema, tumor swelling, and hydrocephalus. Patients were given steroids for 2 days to decrease edema, but no anticoagulants to avoid hemorrhagic infarction of the tumor. Figures 1, 2 , and 3 show three illustrative cases.
Surgical technique
All patients were operated on after embolization according to the location of the tumor and its dural attachment. Timing after embolization was restricted maximally to 21 days. All patients were operated on via a suboccipital approach. Surface coagulation was achieved using bipolar blades and then piecemeal removal was carried out.
Results
Embolization was accomplished in all 10 patients. No procedure-related complications were encountered. Angiographic vascularity of the hemangioblastoma was assessed using a final DSA, which revealed that most of the tumor vessels and tumor stains disappeared in most cases. Total occlusion was obtained in six cases embolized with Onyx. Near total occlusion was observed in three cases. One case embolized with PVA had incomplete occlusion (Table 1) . Follow-up CT revealed no hemorrhage. Late follow-up MRI revealed tumor necrosis in some cases ( Figure 2 ). During surgical excision the bleeding was minimal and controllable. Most bleeding amounts were less than one liter. We observed that the bleeding rate was highest in cases embolized with PVA (Table 1) . However, none of the patients received blood transfusion or died during surgery. The neurological manifestations were reduced or eliminated in all 10 patients. No recurrence occurred during follow-up in patients who underwent total tumor resection. One patient had subtotal excision because the intracranial tension increased during surgery and was difficult to control, so the tumor excision was stopped; however, more than 70% was removed. Postoperative grades using the MRS were improved in all 10 patients.
Complications
Complications included hydrocephalus in one case, which required ventriculoperitoneal (VP) shunt insertion, wound infection in two cases, and cerebrospinal fluid leakage from the incision in one case. Notably, normal perfusion pressure breakthrough did not develop during or after endovascular embolization or surgery. One case had received a VP shunt at another institution before embolization and surgery.
Discussion
Hemangioblastomas are benign tumors which present as a part of VHL disease or as a sporadic lesions affecting the central nervous system. 4, 5 Cerebellar hemangioblastomas and surrounding tissues in the tight posterior fossa have extremely abundant blood supply and are prone to excessive intraoperative hemorrhage, which can hinder the complete resection of the tumor and increase the risk of postoperative morbidity, mortality, and recurrence. Some authors have reported spontaneous hemorrhage in some cases. 1, 6 Massive bleeding with major blood loss can occur during attempts at surgical resection, which resulted in aborting the procedure in many cases. 1,2,5,7 Fukuda et al. reported that two cases of their series were partially resected due to blood loss and cerebellar swelling. 7 They also mentioned that solid lesions with preoperative endovascular embolization were completely resected. In addition, Eskridge et al. reported that two cases of their series had undergone recent attempts at surgical resection at another institution. 2 Liu et al. in their series reported that massive intraoperative bleeding prevented complete resection in eight cases of the control group and that blood loss reached 3240 mL in some cases. 1 In our series, three cases had failed trials of surgical resection before embolization. 
Concept change
Surgical excision of hemangioblastoma depends on identifying major arterial feeders to deal with them first before going inside the tumor and starting resection. However, dealing with major arterial feeders in a 360 manner is very difficult in the tight posterior fossa and may be not possible in large hemispheric cerebellar lesions. Surgical mobilization of the tumor in the tight posterior fossa space to deal with deep feeders carries high morbidity to the critical neural and vascular structures. In our series, there were three cases of previously aborted surgeries because of massive bleeding without preoperative embolization. Preoperative embolization allows occlusion of deep feeders and more importantly filling the tumor with embolic materials to induce its degeneration. This facilitates complete resection of the tumor via a piecemeal technique with minimal risk of major blood loss. [1] [2] [3] 8, 9 The concept of surgery now changes to piecemeal removal rather that one of mass extraction after 360 devascularization, embolic agents available include coils, particles, and liquid agents. 10 The choice of the optimal embolic agent depends on hemodynamic factors and vascular anatomy. Coils can be used to dampen the blood flow of high flow fistulas before usage of other materials. Penetration of smaller tumor vessels is required for effective and successful embolization. This penetration can be achieved with small particles like PVA and Embospheres and liquid agents like NBCA and Onyx. 11 However, small particles can escape and reach pulmonary vessels. Some authors have observed high mortality and morbidity rates with particle embolization. 9 However, other authors, such as Eskridge et al., 2 reported safe embolization using PVA in nine cases, with complete surgical resection. In our series we used PVA in three cases. One case had incomplete occlusion, one case had near total occlusion, and one case had total obliteration. At surgery, the bleeding was controllable and none of the patients required blood transfusion. The bleeding rate ranged from 650-850 mL in the PVA group. Takeuchi et al. reported complete occlusion only in one case in their series using PVA and incomplete occlusion in eight cases. 3 One case had cerebellar infarction after embolization using PVA. 3 Onyx (Covidien/eV3), with its long polymerization time, non-adhesive criteria, and lava-like behavior, has established itself as the most widely used liquid embolic agent for vascular brain lesions with excellent anatomic results and deep penetration. The use of Onyx requires compatible microcatheters and safe distance of reflux on the feeder. We used Onyx in most of our series (6 cases). Total obliteration was achieved, which allowed easy excision of the lesion with minimal bleeding rate. The bleeding rate in the Onyx group ranged from 130-370 mL without the need for transfusion during surgery. Many authors had observed the effectiveness of Onyx for obliteration of brain hemangioblastoma. 2,10-14 n-Butyl cyanoacrylate (NBCA), after replacing the previously known particulate embolic agents before Onyx introduction, has provided relatively good results in vascular brain lesions. NBCA requires multiple super-selective catheterizations on the reverse of Onyx to obliterate the lesion. The rapid polymerization and adhesive characteristics limit the injection time and penetration. 10, 15 We used NBCA in one case of our series with near total obliteration. We used PVA at the start of our series because Onyx was not available in Egypt at that time; NBCA was used in only one case. After introduction of Onyx and its availability in our country we used it in most of our cases. We observed that the obliteration was lower and bleeding rate was higher in cases of PVA than in cases of Onyx. Liu et al. in their series observed that the occlusion rate was better in cases of Onyx than in cases of PVA and NBCA. 1 They also reported that patients achieved complete occlusion by preoperative embolization; intraoperative blood loss ranged from 100-1080 mL during surgical excision. Takeuchi et al. reported complete occlusion only in one case in their series using PVA and incomplete occlusion in eight cases. 3 
Timing of surgery
The timing of surgery after preoperative embolization is variable in the literature, ranging from a few days to 3 weeks. 3 Some practitioners prefer to operate immediately after embolization to avoid any complication due to tumor swelling or tumor apoplexy. 15 Corticosteroids are prescribed to reduce tumor swelling and any vasogenic edema in the adjacent brain. In our experience it is better to wait up to 3 weeks after embolization to appreciate sufficient tumor necrosis ( Figure 2 ) and avoid post-embolization hyperperfusion around the tumors. In our experience, early surgery after tumor embolization especially in meningioma (personal experiences, not published) has significant bleeding from the skin and bone around the tumor, probably because of hyperperfusion-like arteriovenous malformations. Follow-up MRI is required to assess tumor necrosis after embolization.
Conclusion
Preoperative endovascular embolization is a safe and effective adjunctive treatment before surgery of large solid hemangioblastoma. Preoperative embolization improves the technique of microsurgical excision and elevates surgeon confidence in cases of such tightly located very vascular tumors. Embolization changes the concept of this lesion surgery into piecemeal removal rather than a total mass extraction technique. Liquid agents are superior to particles in obliteration of such lesions.
